# Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum

> **NCT05219994** · NA · COMPLETED · sponsor: **University of Missouri-Columbia** · enrollment: 22 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** Hyperoxia Exposure
- **OTHER:** Normoxia Exposure

## Key facts

- **NCT ID:** NCT05219994
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-09
- **Primary completion:** 2023-05-10
- **Final completion:** 2023-05-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05219994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05219994, "Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05219994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*